Dr. Paul Chapman, from Memorial Sloan-Kettering Cancer Center, on Combining BRAF and MEK Inhibitors for Advanced Melanoma
Paul Chapman, MD
Advertisement
Articles by Paul Chapman, MD
Dr. Chapman from Memorial Sloan-Kettering Cancer Center on Vemurafenib Combination Therapies
Dr. Chapman From Memorial Sloan-Kettering Cancer Center Describes Recent Melanoma Advances
Dr. Chapman From Memorial Sloan-Kettering Describes the Vemurafenib Clinical Trial
Dr. Paul Chapman from Memorial Sloan-Kettering Cancer Center Describes the Side Effects of Vemurafenib
Advertisement
Latest Updated Articles
Dr. Chapman Describes the Vemurafenib Clinical TrialJune 10th 2011
Dr. Chapman Describes Recent Melanoma AdvancesJune 15th 2011
Dr. Chapman on Vemurafenib Combination TherapiesJune 16th 2011
Dr. Chapman on BRAF/MEK Combination for MelanomaMay 16th 2012
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
Dr Eads on Early Data for CDH17-Directed CAR T-Cell Therapy in R/R GI Cancers
5